{"article_title": "How To Play The M&amp;A Boom", "article_keywords": ["play", "mampa", "boom"], "article_url": "http://www.forbes.com/sites/jeremyhill/2014/07/20/how-to-play-the-ma-boom/", "article_text": "", "article_metadata": {"prerender-status-code": "{{meta.code}}", "author": "Jeremy Hill", "og": {"site_name": "Forbes", "description": "On Friday, U.S. drug company AbbVie (ABBV) finalized its purchase of Shire Pharmaceuticals (SHP.L) of the UK and Ireland for $54 billion. The deal is the poster child of both the hot pace of global M&A activity and the somewhat controversial trend of companies leaving the U.S. for friendlier tax [...]", "title": "How To Play The M&amp;A Boom", "url": "http://www.forbes.com/sites/jeremyhill/2014/07/20/how-to-play-the-ma-boom/", "image": "http://blogs-images.forbes.com/jeremyhill/files/2014/07/Cash-to-Debt-Ratio-Top-5-Sectors.7.20.14.png", "updated_time": "2014-07-21T12:18:50-04:00", "type": "article"}, "twitter": {"description": "On Friday, U.S. drug company AbbVie (ABBV) finalized its purchase of Shire Pharmaceuticals (SHP.L) of the UK and Ireland for $54 billion. The deal is the poster child of both the hot pace of global M&A activity and the somewhat controversial trend of companies leaving the U.S. for friendlier tax [...]", "title": "How To Play The M&amp;A Boom", "image": "http://blogs-images.forbes.com/jeremyhill/files/2014/07/Cash-to-Debt-Ratio-Top-5-Sectors.7.20.14.png", "creator": "@JHILLMacro", "site": "@forbes", "card": "summary_large_image"}, "description": "On Friday, U.S. drug company AbbVie (ABBV) finalized its purchase of Shire Pharmaceuticals (SHP.L) of the UK and Ireland for $54 billion. The deal is the poster child of both the hot pace of global M&A activity and the somewhat controversial trend of companies leaving the U.S. for friendlier tax [...]", "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Economics,Exit Strategy,Investing,Markets,Stocks,Wall Street,Economics &amp; Finance,acquisition,deal,Evercore,financing,Greenhill,investment banking,Lazard,M&amp;A,merger,Moelis,transaction", "article": {"publisher": "https://www.facebook.com/forbes", "section_url": "http://www.forbes.com/wall-street", "section": "Wall Street", "modified": "2014-07-21", "published": "2014-07-20", "id": "blogAndPostId/blog/post/2926-170"}, "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "news_keywords": "Economics,Exit Strategy,Investing,Markets,Stocks,Wall Street,Economics &amp; Finance,acquisition,deal,Evercore,financing,Greenhill,investment banking,Lazard,M&amp;A,merger,Moelis,transaction"}, "_id": "\"57477af36914bd0286fd1606\"", "article_summary": ""}